翔宇医疗
(688626)
| 流通市值：46.18亿 | | | 总市值：46.18亿 |
| 流通股本：1.60亿 | | | 总股本：1.60亿 |
| 报告期 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 337,859,279.17 | 169,097,488.82 | 744,810,202.47 | 541,877,308 |
| 营业收入 | 337,859,279.17 | 169,097,488.82 | 744,810,202.47 | 541,877,308 |
| 二、营业总成本 | 285,343,029.29 | 132,060,066.08 | 529,660,254.67 | 379,310,217.28 |
| 营业成本 | 107,375,921.06 | 52,724,229.1 | 233,715,371.97 | 170,236,127.57 |
| 税金及附加 | 5,018,819.44 | 2,087,387.54 | 8,106,302.72 | 5,933,039.08 |
| 销售费用 | 94,579,113.57 | 36,898,012.62 | 169,918,015.59 | 124,720,506.5 |
| 管理费用 | 23,972,826.81 | 15,624,915.37 | 40,986,130.29 | 26,981,645.32 |
| 研发费用 | 65,668,279.41 | 29,562,422.95 | 106,747,769.86 | 72,931,856.49 |
| 财务费用 | -11,271,931 | -4,836,901.5 | -29,813,335.76 | -21,492,957.68 |
| 其中:利息费用 | 1,812,293.85 | 498,888.9 | 2,660,560.3 | 1,487,198.18 |
| 其中:利息收入 | 11,928,505.38 | 6,397,019.84 | 29,530,828.81 | 21,047,751.32 |
| 加:投资收益 | 1,337,909.86 | 1,019,841.02 | 9,293,049.12 | 7,535,513.47 |
| 资产处置收益 | 12,898.25 | - | 12,426.55 | - |
| 资产减值损失(新) | -3,056,971.77 | -1,388,013.1 | -12,116,839.98 | -6,744,134.34 |
| 信用减值损失(新) | -1,244,591.04 | -960,374.9 | -2,953,326.65 | -1,061,229.22 |
| 其他收益 | 11,764,138.31 | 6,501,064.35 | 35,243,946.63 | 25,763,621.23 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 61,329,633.49 | 42,209,940.11 | 244,629,203.47 | 188,060,861.86 |
| 加:营业外收入 | 59,775.89 | 17,886.13 | 1,574,462.28 | 67,801.15 |
| 减:营业外支出 | 271,387.22 | 0 | 2,172,336.11 | 2,152,995.66 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 61,118,022.16 | 42,227,826.24 | 244,031,329.64 | 185,975,667.35 |
| 减:所得税费用 | 4,527,243.87 | 3,501,843.58 | 15,717,382.44 | 5,774,610.81 |
| 六、净利润 | 56,590,778.29 | 38,725,982.66 | 228,313,947.2 | 180,201,056.54 |
| 持续经营净利润 | 56,590,778.29 | 38,725,982.66 | 228,313,947.2 | 180,201,056.54 |
| 归属于母公司股东的净利润 | 56,635,866.17 | 39,073,828.52 | 227,142,672.51 | 179,162,478.4 |
| 少数股东损益 | -45,087.88 | -347,845.86 | 1,171,274.69 | 1,038,578.14 |
| (一)基本每股收益 | 0.36 | 0.25 | 1.44 | 1.14 |
| (二)稀释每股收益 | 0.4 | 0.26 | 1.46 | 1.14 |
| 九、综合收益总额 | 56,590,778.29 | 38,725,982.66 | 228,313,947.2 | 180,201,056.54 |
| 归属于母公司股东的综合收益总额 | 56,635,866.17 | 39,073,828.52 | 227,142,672.51 | 179,162,478.4 |
| 归属于少数股东的综合收益总额 | -45,087.88 | -347,845.86 | 1,171,274.69 | 1,038,578.14 |
| 公告日期 | 2024-08-30 | 2024-04-18 | 2024-04-18 | 2023-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |